Literature DB >> 33449412

Therapeutic potential and pharmacological activities of β-eudesmol.

Bishwanath Acharya1, Wanna Chaijaroenkul1,2, Kesara Na-Bangchang1,2,3.   

Abstract

Herbal medicines are attracting the attention of researchers worldwide. β-Eudesmol is one of the most studied and major bioactive sesquiterpenes, mainly extracted from Atractylodes lancea (Thunb) DC. rhizomes. It has potential anti-tumor and anti-angiogenic activities and is an inhibitor of tumor growth by inhibiting angiogenesis by suppressing CREB activation of the growth factor signaling pathway. It also stimulates neurite outgrowth in rat pheochromocytoma cells with activation of mitogen-activated protein kinases. It may be a promising lead compound for enhancing neural function, and it may help to explain the underlying mechanisms of neural differentiation. In this review, we summarized the currently available clinical and preclinical studies describing the therapeutic applications of β-eudesmol.
© 2021 John Wiley & Sons A/S.

Entities:  

Keywords:  zzm321990Atractylodes lanceazzm321990; bioactive sesquiterpenes; β-eudesmol

Year:  2021        PMID: 33449412     DOI: 10.1111/cbdd.13823

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  6 in total

1.  In vitro production of atractylon and β-eudesmol from Atractylodes chinensis by adventitious root culture.

Authors:  Cholil Yun; Zhuowen Zhao; Lin Gu; Zhonghua Zhang; Shengfang Wang; Yutong Shi; Na Miao; Ilbong Ri; Wenjie Wang; Huimei Wang
Journal:  Appl Microbiol Biotechnol       Date:  2022-09-29       Impact factor: 5.560

2.  Barley microgreen incorporation in diet-controlled diabetes and counteracted aflatoxicosis in rats.

Authors:  Sara M Mohamed; Emam A Abdel-Rahim; Tahany Aa Aly; AbdelMoneim M Naguib; Marwa S Khattab
Journal:  Exp Biol Med (Maywood)       Date:  2021-11-19

3.  Profiles of Essential Oils and Correlations with Phenolic Acids and Primary Metabolites in Flower Buds of Magnolia heptapeta and Magnolia denudata var. purpurascens.

Authors:  Hyejin Hyeon; Ho Bong Hyun; Boram Go; Sung Chun Kim; Yong-Hwan Jung; Young-Min Ham
Journal:  Molecules       Date:  2021-12-30       Impact factor: 4.411

Review 4.  Research Advances in Cardio-Cerebrovascular Diseases of Ligusticum chuanxiong Hort.

Authors:  Dan Li; Yu Long; Shuang Yu; Ai Shi; Jinyan Wan; Jing Wen; Xiaoqiu Li; Songyu Liu; Yulu Zhang; Nan Li; Chuan Zheng; Ming Yang; Lin Shen
Journal:  Front Pharmacol       Date:  2022-01-31       Impact factor: 5.810

5.  Mechanisms of magnoliae cortex on treating sarcopenia explored by GEO gene sequencing data combined with network pharmacology and molecular docking.

Authors:  Xingqi Zhao; Feifei Yuan; Haoyang Wan; Hanjun Qin; Nan Jiang; Bin Yu
Journal:  BMC Genom Data       Date:  2022-02-17

Review 6.  Chemical Variability and Pharmacological Potential of Propolis as a Source for the Development of New Pharmaceutical Products.

Authors:  Piotr Paweł Wieczorek; Nataliia Hudz; Oksana Yezerska; Vladimira Horčinová-Sedláčková; Mariia Shanaida; Oleksii Korytniuk; Iza Jasicka-Misiak
Journal:  Molecules       Date:  2022-02-28       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.